Toronto Dominion Bank Buys New Shares in Oscar Health, Inc. (NYSE:OSCR)

Toronto Dominion Bank bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 75,000 shares of the company's stock, valued at approximately $1,008,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC increased its stake in shares of Oscar Health by 171.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after purchasing an additional 4,185 shares during the last quarter. KBC Group NV increased its position in Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after buying an additional 2,555 shares during the last quarter. Alberta Investment Management Corp bought a new stake in shares of Oscar Health in the fourth quarter valued at $138,000. Virtu Financial LLC bought a new stake in shares of Oscar Health in the fourth quarter valued at $140,000. Finally, Potentia Wealth bought a new position in shares of Oscar Health during the 4th quarter worth $141,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on OSCR shares. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Wall Street Zen upgraded Oscar Health from a "hold" rating to a "buy" rating in a research note on Saturday. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $18.50.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now directly owns 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 24.39% of the company's stock.

Oscar Health Stock Performance

Shares of NYSE:OSCR traded down $0.00 during midday trading on Tuesday, reaching $14.26. 11,666,405 shares of the company traded hands, compared to its average volume of 5,654,147. The firm's fifty day moving average price is $13.74 and its two-hundred day moving average price is $14.59. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79. The firm has a market capitalization of $3.63 billion, a price-to-earnings ratio of -713.09 and a beta of 1.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company's revenue was up 42.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.62 earnings per share. On average, equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.